Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AGN

Allergan (AGN) Stock Price, News & Analysis

Allergan logo

About Allergan Stock (NYSE:AGN)

Key Stats

Today's Range
$191.64
$193.38
50-Day Range
$184.04
$193.89
52-Week Range
$114.27
$202.21
Volume
12.44 million shs
Average Volume
4.01 million shs
Market Capitalization
$63.50 billion
P/E Ratio
N/A
Dividend Yield
1.53%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergan and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGN Stock News Headlines

This Biotech has a clinical approach that intrigues investors
This biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. Basket trials test a single drug across several rare diseases, saving time and multiplying upside. More shots on goal means more chances to win. It's a smart setup - designed by a PROVEN team with a $680M exit already - to reduce risk and accelerate potential progress across multiple indications.tc pixel
See More Headlines

AGN Stock Analysis - Frequently Asked Questions

Allergan plc (NYSE:AGN) posted its quarterly earnings data on Monday, February, 10th. The company reported $5.22 EPS for the quarter, topping analysts' consensus estimates of $4.57 by $0.65. The business's revenue was up 6.6% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Allergan investors own include Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU) and Aegean Marine Petroleum Network (ANW).

Company Calendar

Last Earnings
2/10/2020
Today
10/02/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:AGN
Previous Symbol
NYSE:ACT
CIK
1578845
Fax
N/A
Employees
17,400
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$17.64
Trailing P/E Ratio
N/A
Forward P/E Ratio
11.56
P/E Growth
1.63
Net Income
-$5.27 billion
Net Margins
-15.44%
Pretax Margin
N/A
Return on Equity
8.46%
Return on Assets
5.31%

Debt

Debt-to-Equity Ratio
0.31
Current Ratio
1.01
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$16.09 billion
Price / Sales
3.95
Cash Flow
$36.70 per share
Price / Cash Flow
5.26
Book Value
$177.28 per share
Price / Book
1.09

Miscellaneous

Outstanding Shares
329,002,000
Free Float
N/A
Market Cap
$63.50 billion
Optionable
Optionable
Beta
1.20
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:AGN) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners